Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma

References

• Au W Y, Pang A, Choy C, Chim C S, Kwong Y L. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004; 104: 243–249
   PubMed Web of Science ®Google Scholar
• Lei K I, Chan L Y, Chan W Y, Johnson P J, Lo Y M. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. Clin Cancer Res 2002; 8: 29–34
   PubMed Web of Science ®Google Scholar
• Incomserb P, Bhattarakosol P, Kulwichit W, Chantratita W, Hansasuta P. Establishment of real-time polymerase chain reaction-based assay for quantitation of Epstein-Barr virus DNA in healthy donors and in patients with EBV associated lymphoma. J Med Assoc Thai 2005; 88(Suppl 4)S280–S286
   PubMedGoogle Scholar
• Park S, Lee J, Ko Y H, Han A, Jun H J, Lee S C, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007; 110: 972–978
   PubMed Web of Science ®Google Scholar
• Kwon J M, Park Y H, Kang J H, Kim K, Ko Y H, Ryoo B Y, et al. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma. Ann Hematol 2006; 85: 463–468
   PubMed Web of Science ®Google Scholar
• Ishii H, Ogino T, Berger C, Kochli-Schmitz N, Nagato T, Takahara M, et al. Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma. J Med Virol 2007; 79: 562–572
   PubMed Web of Science ®Google Scholar
• Chan A T, Lo Y M, Zee B, Chan L Y, Ma B B, Leung S F, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 2002; 94: 1614–1619
   PubMed Web of Science ®Google Scholar
• Lin J C, Wang W Y, Chen K Y, Wei Y H, Liang W M, Jan J S, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004; 350: 2461–2470
   PubMed Web of Science ®Google Scholar
• Cheson B D, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244
   PubMed Web of Science ®Google Scholar
• Lee J, Suh C, Park Y H, Ko Y H, Bang S M, Lee J H, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24: 612–618
   PubMed Web of Science ®Google Scholar
• Lee J, Park Y H, Kim W S, Lee S S, Ryoo B Y, Yang S H, et al. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005; 41: 1402–1408
   PubMed Web of Science ®Google Scholar
• Lin J C, Chen K Y, Wang W Y, Jan J S, Liang W M, Tsai C S, et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival. J Clin Oncol 2001; 19: 2607–2615
   PubMed Web of Science ®Google Scholar
• Leung E, Shenton B K, Jackson G, Gould F K, Yap C, Talbot D. Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood. J Immunol Methods 2002; 270: 259–267
   PubMed Web of Science ®Google Scholar
• Wagner H J, Fischer L, Jabs W J, Holbe M, Pethig K, Bucsky P. Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction. Transplantation 2002; 74: 656–664
   PubMed Web of Science ®Google Scholar
• Frias C, Lauzurica R, Bayes B, Ausina V. Prospective follow-up of Epstein-Barr virus load in adult kidney transplant recipients by semiquantitative polymerase chain reaction in blood and saliva samples. Eur J Clin Microbiol Infect Dis 2001; 20: 892–895
   PubMed Web of Science ®Google Scholar
• Kojima M, Motoori T, Itoh H, Shimizu K, Iijima M, Tamaki Y, et al. Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis) with associated lymphadenopathy: a study of 49 cases. Int J Surg Pathol 2005; 13: 273–278
   PubMed Web of Science ®Google Scholar
• Schifter T, Lewinski U H. Adult onset Still's disease associated with Epstein-Barr virus infection in a 66-year-old woman. Scand J Rheumatol 1998; 27: 458–460
   PubMed Web of Science ®Google Scholar
• Moon U Y, Park S J, Oh S T, Kim W U, Park S H, Lee S H, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 2004; 6: R295–R302
   PubMed Web of Science ®Google Scholar
• Lu J J, Chen D Y, Hsieh C W, Lan J L, Lin F J, Lin S H. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 2007; 16: 168–175
   PubMed Web of Science ®Google Scholar
• Lei K I, Chan L Y, Chan W Y, Johnson P J, Lo Y M. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol 2000; 111: 239–246
   PubMed Web of Science ®Google Scholar
• Fafi-Kremer S, Brengel-Pesce K, Bargues G, Bourgeat M J, Genoulaz O, Seigneurin J M, et al. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. J Clin Virol 2004; 30: 157–164
   PubMed Web of Science ®Google Scholar
• Wagner H J, Jabs W, Smets F, Wessel M, Fischer L, Offner G, et al. Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells. Klin Padiatr 2000; 212: 206–210
   PubMed Web of Science ®Google Scholar
• Stevens S J, Pronk I, Middeldorp J M. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol 2001; 39: 1211–1216
   PubMed Web of Science ®Google Scholar
• Wadowsky R M, Laus S, Green M, Webber S A, Rowe D. Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. J Clin Microbiol 2003; 41: 5245–5249
   PubMed Web of Science ®Google Scholar
• Yang J, Tao Q, Flinn I W, Murray P G, Post L E, Ma H, et al. Characterization of Epstein-Barr virus-infected B cells in patients with post-transplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood 2000; 96: 4055–4063
   PubMed Web of Science ®Google Scholar
• Gallagher A, Armstrong A A, MacKenzie J, Shield L, Khan G, Lake A, et al. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer 1999; 84: 442–448
   PubMed Web of Science ®Google Scholar